DURABOLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Durabolin, and when can generic versions of Durabolin launch?
Durabolin is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in DURABOLIN is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
Summary for DURABOLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 2 |
Patent Applications: | 5,613 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DURABOLIN at DailyMed |
Recent Clinical Trials for DURABOLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Morten Tange Kristensen PT, PhD | Phase 2 |
University Hospital Ostrava | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for DURABOLIN
US Patents and Regulatory Information for DURABOLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |